Long COVID might be a bigger problem than researchers thought
Long COVID may be affecting people who were asymptomatic during their infections at a higher rate than researchers expected, a new study conducted by the nonprofit FAIR Health suggests, The New York Times reports.
The study analyzed the health insurance records of 2 million people diagnosed with COVID-19 and found that 23 percent of them later sought medical treatment for new conditions. Among the overall group, rates were highest for people who had dealt with serious bouts of the disease, but even 19 percent of the people who were asymptomatic experienced subsequent medical issues, a figure that surprised FAIR Health's research team, the organization's president Robin Gelburd told the Times.
The study deserves praise for its size and "ability to look across the range of disease severity in a diversity of age groups," said Dr. Helen Chu, a professor of medicine and infectious disease at the University of Washington School of Medicine. At the same time, like most studies, it doesn't paint a complete a picture. Per the Times, it's possible that some of the asymptomatic patients later developed symptoms after their diagnosis, and the study also doesn't compare people who had COVID-19 with those who didn't, so it's not clear whether the medical treatment rates are similar. On the latter point, though, smaller studies have suggested that previously infected patients do, in fact, require treatment more often. Read more at The New York Times.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Nicolás Maduro: from bus driver to Venezuela’s presidentIn the Spotlight Shock capture by US special forces comes after Maduro’s 12-year rule proved that ‘underestimating him was a mistake’
-
Artemis II: back to the MoonThe Explainer Four astronauts will soon be blasting off into deep space – the first to do so in half a century
-
The Night Manager series two: ‘irresistible’ follow-up is ‘smart, compelling’ TVThe Week Recommends Second instalment of the spy thriller keeps its ‘pace’, ‘intrigue’ and ‘sly sexiness’
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
